NEW YORK (Reuters) – Pfizer Inc and BioNTech SE will exceed their original global target for COVID-19 vaccines by as much as 20% this year,
Read moreHome »
Slideshow ( 2 images )ZURICH (Reuters) – Swiss drugmaker Roche said on Thursday that adding its drug Actemra to Gilead Sciences remdesivir, or Veklury, in
Read more(Reuters) – GlaxoSmithKline and Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate, reviving their efforts against
Read moreJOHANNESBURG (Reuters) – Scientists will meet on Thursday to advise South Africa’s government on its next steps after a study suggested the dominant local coronavirus
Read more